Don't Assume DOACs are Preferred for All Patients with Venous Thromboembolism

We're getting questions about which anticoagulant to use to TREAT venous thromboembolism (VTE).

New guidelines give preference to direct oral anticoagulants (DOACs)...such as Eliquis (apixaban) or Xarelto (rivaroxaban).

But don't assume that DOACs are the best choice for everyone.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote